Consolidated Statement of Shareholders Equity (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Common Stock Held In Trust [Member]	Deferred Compensation Obligation [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance (in shares) at Feb. 29, 2020	26,443
Beginning balance at Feb. 29, 2020	$ 516,778	$ 8,814	$ 154,016	$ 388,010	$ (685)	$ 685	$ (34,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	2,876			2,876
Unrealized gain (loss) on marketable securities, net of tax expense (benefit)	97						97
Tax expense (benefit) on marketable securities	26
Tax expense (benefit) on derivatives	(189)
Foreign currency translation adjustments	$ (6,151)						(6,151)
Issuance of stock, net of cancellations (Shares)	183
Issuance of stock, net of cancellations	$ 23	62	(39)		(11)	11
Share-based compensation	$ 1,406		1,406
Share repurchases, Shares	(231)
Share repurchases	$ (4,731)	(77)	(1,370)	(3,284)
Other share retirements, Shares	(26)
Other share retirements	$ (665)	(9)	(151)	(505)
Dividends, Common Stock, Cash	$ (4,872)			(4,872)
Ending balance (in shares) at May. 30, 2020	26,369
Ending balance at May. 30, 2020	$ 504,144	8,790	153,862	382,225	(696)	696	(40,733)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized (loss) gain on derivative instruments, net of $(265), $90, $(257) and $305 of tax (benefit) expense, respectively	$ (617)						(617)
Beginning balance (in shares) at Feb. 29, 2020	26,443
Beginning balance at Feb. 29, 2020	$ 516,778	8,814	154,016	388,010	(685)	685	(34,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	57,807
Unrealized gain (loss) on marketable securities, net of tax expense (benefit)	145
Tax expense (benefit) on marketable securities	39
Tax expense (benefit) on derivatives	$ 305
Ending balance (in shares) at Nov. 28, 2020	25,962
Ending balance at Nov. 28, 2020	$ 547,343	8,654	155,974	414,749	(183)	183	(32,034)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized (loss) gain on derivative instruments, net of $(265), $90, $(257) and $305 of tax (benefit) expense, respectively	$ 997
Beginning balance (in shares) at May. 30, 2020	26,369
Beginning balance at May. 30, 2020	$ 504,144	8,790	153,862	382,225	(696)	696	(40,733)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	17,658			17,658
Unrealized gain (loss) on marketable securities, net of tax expense (benefit)	50						50
Tax expense (benefit) on marketable securities	13
Tax expense (benefit) on derivatives	404
Foreign currency translation adjustments	$ 6,139						6,139
Issuance of stock, net of cancellations (Shares)	121
Issuance of stock, net of cancellations	$ 18	41	(23)		(11)	11
Share-based compensation	$ 2,256		2,256
Other share retirements, Shares	(23)
Other share retirements	$ (537)	(8)	(139)	(390)
Dividends, Common Stock, Cash	$ (4,879)			(4,879)
Ending balance (in shares) at Aug. 29, 2020	26,467
Ending balance at Aug. 29, 2020	$ 526,168	8,823	155,956	394,614	(707)	707	(33,225)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized (loss) gain on derivative instruments, net of $(265), $90, $(257) and $305 of tax (benefit) expense, respectively	1,319						1,319
Net earnings	37,273			37,273
Unrealized gain (loss) on marketable securities, net of tax expense (benefit)	(2)						(2)
Tax expense (benefit) on marketable securities	0
Tax expense (benefit) on derivatives	90
Foreign currency translation adjustments	$ 899						899
Issuance of stock, net of cancellations (Shares)	10
Issuance of stock, net of cancellations	$ 18	3	15		524	(524)
Share-based compensation	$ 2,501		2,501
Exercise of stock options (shares)	127
Exercise of stock options	$ 1,456	42	1,414
Share repurchases, Shares	(620)
Share repurchases	$ (16,000)	(207)	(3,781)	(12,012)
Other share retirements, Shares	(22)
Other share retirements	$ (469)	(7)	(131)	(331)
Dividends, Common Stock, Cash	$ (4,795)			(4,795)
Ending balance (in shares) at Nov. 28, 2020	25,962
Ending balance at Nov. 28, 2020	$ 547,343	8,654	155,974	414,749	(183)	183	(32,034)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized (loss) gain on derivative instruments, net of $(265), $90, $(257) and $305 of tax (benefit) expense, respectively	$ 294						294
Beginning balance (in shares) at Feb. 27, 2021	25,714
Beginning balance at Feb. 27, 2021	$ 492,745	8,571	154,958	357,243	(186)	186	(28,027)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	10,817			10,817
Tax expense (benefit) on marketable securities	0
Tax expense (benefit) on derivatives	211
Foreign currency translation adjustments	$ 5,880						5,880
Issuance of stock, net of cancellations (Shares)	90
Issuance of stock, net of cancellations	$ 23	30	(7)		(3)	3
Share-based compensation	$ 1,674		1,674
Exercise of stock options (shares)	179
Exercise of stock options	$ 4,115	60	4,055
Share repurchases, Shares	(357)
Share repurchases	$ (12,625)	(119)	(2,218)	(10,288)
Other share retirements, Shares	(20)
Other share retirements	$ (735)	(7)	(121)	(607)
Dividends, Common Stock, Cash	$ (5,035)			(5,035)
Ending balance (in shares) at May. 29, 2021	25,606
Ending balance at May. 29, 2021	$ 497,551	8,535	158,341	352,130	(189)	189	(21,455)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized (loss) gain on derivative instruments, net of $(265), $90, $(257) and $305 of tax (benefit) expense, respectively	$ 692						692
Beginning balance (in shares) at Feb. 27, 2021	25,714
Beginning balance at Feb. 27, 2021	$ 492,745	8,571	154,958	357,243	(186)	186	(28,027)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	19,759
Unrealized gain (loss) on marketable securities, net of tax expense (benefit)	(147)
Tax expense (benefit) on marketable securities	(39)
Tax expense (benefit) on derivatives	$ (257)
Ending balance (in shares) at Nov. 27, 2021	25,227
Ending balance at Nov. 27, 2021	$ 473,853	8,409	158,579	336,816	(195)	195	(29,951)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized (loss) gain on derivative instruments, net of $(265), $90, $(257) and $305 of tax (benefit) expense, respectively	$ (842)
Beginning balance (in shares) at May. 29, 2021	25,606
Beginning balance at May. 29, 2021	$ 497,551	8,535	158,341	352,130	(189)	189	(21,455)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	(2,116)			(2,116)
Unrealized gain (loss) on marketable securities, net of tax expense (benefit)	4						4
Tax expense (benefit) on marketable securities	2
Tax expense (benefit) on derivatives	(203)
Foreign currency translation adjustments	$ (4,300)						(4,300)
Issuance of stock, net of cancellations (Shares)	67
Issuance of stock, net of cancellations	$ 22	22	0		(3)	3
Share-based compensation	$ 1,587		1,587
Share repurchases, Shares	(249)
Share repurchases	$ (9,794)	(83)	(1,616)	(8,095)
Other share retirements, Shares	(30)
Other share retirements	$ (702)	(9)	(197)	(496)
Dividends, Common Stock, Cash	$ (5,025)			(5,025)
Ending balance (in shares) at Aug. 28, 2021	25,394
Ending balance at Aug. 28, 2021	$ 476,561	8,465	158,115	336,398	(192)	192	(26,417)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized (loss) gain on derivative instruments, net of $(265), $90, $(257) and $305 of tax (benefit) expense, respectively	(666)						(666)
Net earnings	11,057			11,057
Unrealized gain (loss) on marketable securities, net of tax expense (benefit)	(151)						(151)
Tax expense (benefit) on marketable securities	(40)
Tax expense (benefit) on derivatives	(265)
Foreign currency translation adjustments	$ (2,515)						(2,515)
Issuance of stock, net of cancellations (Shares)	1
Issuance of stock, net of cancellations	$ 22	0	22		(3)	3
Share-based compensation	$ 1,546		1,546
Share repurchases, Shares	(166)
Share repurchases	$ (6,745)	(55)	(1,092)	(5,598)
Other share retirements, Shares	(2)
Other share retirements	$ (64)	(1)	(12)	(51)
Dividends, Common Stock, Cash	$ (4,990)			(4,990)
Ending balance (in shares) at Nov. 27, 2021	25,227
Ending balance at Nov. 27, 2021	$ 473,853	$ 8,409	$ 158,579	$ 336,816	$ (195)	$ 195	(29,951)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized (loss) gain on derivative instruments, net of $(265), $90, $(257) and $305 of tax (benefit) expense, respectively	$ (868)						$ (868)